Establishment of H5-specific ELISpot and B cell flow cytometry to investigate memory B cell responses induced by avian influenza A(H5N8) vaccination
Ladataan...
suljettu
Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.
Lataukset4
Pysyvä osoite
Verkkojulkaisu
DOI
Tiivistelmä
Highly pathogenic avian influenza A(H5N1) virus has resulted in several outbreaks in domestic and wild birds globally, creating the need for a vaccine to prevent human transmission. Zoonotic influenza A(H5N8) vaccine by Seqirus was approved in 2023 in order to protect against H5 subtype influenza A viruses, including the highly pathogenic clade 2.3.4.4b A(H5N1) avian influenza virus infection. The B cell responses this vaccine induces have not been extensively investigated. Thus, the aim of this study was to develop hemagglutinin H5 specific ELISpot and memory B cell flow cytometry to investigate B cell responses induced by the H5N8 vaccine.
Stored PBMCs from H5N8-vaccinated and non-H5N8-vaccinated individuals were used for setting up the methods. For ELISpot, PBMCs were incubated with R848 and IL-2 to activate B cells. Subsequently, antibody secreting cells specific for recombinant HA-proteins of H5 and H1 subtypes, and H5N1 vaccine (A/Indonesia/05/2005 Vaccine), as well as for SARS-CoV-2 S1 and IgG, were detected on coated ELISpot plates. The detection of the antibody-secreting cells was optimized by testing a two-step detection method using biotin and streptavidin-alkaline phosphatase, after which it was compared to a one-step detection method using alkaline phosphatase. For memory B cell flow cytometry, PBMCs were labelled with anti-CD3, anti-CD19, and anti-IgD. The H5 HA-specific cells were detected with additional dual-labelling using lighting link AF647, and PE-probed recombinant HA1-subunit of H5. To achieve optimal detection, the optimization included testing T-cell depletion and different amounts of dual-labelled H5 HA.
As a result, we were able to develop functional H5 HA-specific ELISpot and memory B cell flow cytometry. In ELISpot, SARS-CoV-2 S1-specific antibody-secreting cells were detected in all study participants, and the number of H5 HA- and H5N1 vaccine-specific responses were increased in H5N8 vaccinees. In the memory B cell flow cytometry, the number of H5 HA-specific memory B cells was four times higher in the samples from H5N8 vaccinees than from the non-H5N8-vaccinees. Due to the limited sample size, these results should be considered preliminary, and further studies with larger sample cohorts are required to properly assess the quantitative changes of these responses.